{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T04:45:32Z","timestamp":1772945132524,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ymgme.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T12:54:07Z","timestamp":1589201647000},"page":"197-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model"],"prefix":"10.1016","volume":"130","author":[{"given":"Ludovica","family":"Santi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"De Ponti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Dina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Pievani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Riminucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaukat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Sawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Antolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Annoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Quattrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-7-22","article-title":"Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure","volume":"7","author":"de Ru","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2020.05.001_bb0010","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/ard.2008.095315","article-title":"Musculoskeletal manifestations of lysosomal storage disorders","volume":"68","author":"Aldenhoven","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2020.05.001_bb0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2020.05.001_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","article-title":"Early initiation of enzyme replacement therapy for the mucopolysaccharidoses","volume":"111","author":"Muenzer","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgme.2020.05.001_bb0025","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1517\/14712598.8.7.1003","article-title":"Laronidase (Aldurazyme): enzyme replacement therapy for mucopolysaccharidosis type I","volume":"8","author":"Pastores","year":"2008","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"5","key":"10.1016\/j.ymgme.2020.05.001_bb0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The Clinical Outcome of Hurler Syndrome after Stem Cell Transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-016-0470-7","article-title":"Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation","volume":"11","author":"Schmidt","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2020.05.001_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10545-015-9900-2","article-title":"Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?","volume":"39","author":"Tomatsu","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2020.05.001_bb0045","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ana.24246","article-title":"Early treatment is associated with improved cognition in Hurler syndrome: early UCBT in MPS1","volume":"76","author":"Poe","year":"2014","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ymgme.2013.03.005","article-title":"Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice","volume":"109","author":"Baldo","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2020.05.001_bb0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2014.05.013","article-title":"Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: Early treatment rescues bone lesions?","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09958-9","article-title":"Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I","volume":"7","author":"Azario","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ymgme.2020.05.001_bb0065","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2014-06-581207","article-title":"Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I","volume":"125","author":"Pievani","year":"2015","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.ymgme.2020.05.001_bb0070","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","article-title":"Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning","volume":"121","author":"Boelens","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ymgme.2020.05.001_bb0075","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2015.02.011","article-title":"Hematopoietic cell transplantation for Mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines","volume":"21","author":"Aldenhoven","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12881-016-0284-4","article-title":"12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment","volume":"17","author":"Gabrielli","year":"2016","journal-title":"BMC Med. Genet."},{"issue":"8","key":"10.1016\/j.ymgme.2020.05.001_bb0085","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1399-3046.2011.01595.x","article-title":"Variable disease progression after successful stem cell transplantation: prospective follow-up investigations in eight patients with hurler syndrome: follow-up after stem cell transplantation in patients with hurler syndrome","volume":"15","author":"Grigull","year":"2011","journal-title":"Pediatr. Transplant."},{"issue":"7\u20138","key":"10.1016\/j.ymgme.2020.05.001_bb0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1440-1754.2009.01537.x","article-title":"Combined enzyme replacement and haematopoietic stem cell transplantation in Hurler syndrome","volume":"45","author":"Bijarnia","year":"2009","journal-title":"J. Paediatr. Child Health"},{"issue":"3","key":"10.1016\/j.ymgme.2020.05.001_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymgme.2016.01.011","article-title":"Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10year combined experience of 2 centres","volume":"117","author":"Ghosh","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2020.05.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2009-2843","article-title":"Laronidase for Cardiopulmonary Disease in Hurler Syndrome 12 Years After Bone Marrow Transplantation","volume":"126","author":"Valayannopoulos","year":"2010","journal-title":"PEDIATRICS"},{"issue":"6","key":"10.1016\/j.ymgme.2020.05.001_bb0105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.bmt.1705934","article-title":"Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome","volume":"41","author":"Tolar","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"10.1016\/j.ymgme.2020.05.001_bb0110","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3324\/haematol.2011.058644","article-title":"Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler\u2019s syndrome after pharmacological enzyme replacement therapy","volume":"97","author":"Saif","year":"2012","journal-title":"Haematologica"},{"issue":"24","key":"10.1016\/j.ymgme.2020.05.001_bb0115","first-page":"7075","article-title":"Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I","volume":"24","author":"Kuehn","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2020.05.001_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine \u03b1-L-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2020.05.001_bb0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10545-012-9522-x","article-title":"Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII","volume":"36","author":"Rowan","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2020.05.001_bb0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1096-7192(03)00116-1","article-title":"Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow","volume":"79","author":"Zheng","year":"2003","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-016-9981-6","article-title":"Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry","volume":"40","author":"Kubaski","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2020.05.001_bb0140","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1369\/jhc.6A7156.2007","article-title":"Actin-binding Proteins Coronin-1a and IBA-1 are Effective Microglial Markers for Immunohistochemistry","volume":"55","author":"Ahmed","year":"2007","journal-title":"J. Histochem. Cytochem"},{"issue":"5","key":"10.1016\/j.ymgme.2020.05.001_bb0145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human \u03b1-L-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin. Hematol."},{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13023-017-0662-9","article-title":"Open issues in Mucopolysaccharidosis type I-Hurler","volume":"12","author":"Parini","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"13","key":"10.1016\/j.ymgme.2020.05.001_bb0160","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ymgme.2020.05.001_bb0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.GIM.0000154299.22120.6A","article-title":"Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome","volume":"7","author":"Grewal","year":"2005","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.bmt.1705401","article-title":"Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome","volume":"38","author":"Cox-Brinkman","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"10.1016\/j.ymgme.2020.05.001_bb0175","article-title":"Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"118","author":"Dickson","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2020.05.001_bb0180","doi-asserted-by":"crossref","unstructured":"K. P. Ponder, Immune response hinders therapy for lysosomal storage diseases\u00bb, J. Clin. Invest, 2008;118(8), ., 2008;118(8), doi: https:\/\/doi.org\/10.1172\/JCI36521.","DOI":"10.1172\/JCI36521"},{"issue":"5","key":"10.1016\/j.ymgme.2020.05.001_bb0185","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ymthe.2017.03.025","article-title":"Hematopoietic stem cell gene therapy for storage disease: current and new indications","volume":"25","author":"Biffi","year":"2017","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ymgme.2020.05.001_bb0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ymgme.2013.09.013","article-title":"Enzyme augmentation therapy enhances the therapeutic efficacy of bone marrow transplantation in mucopolysaccharidosis type II mice","volume":"111","author":"Akiyama","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2020.05.001_bb0195","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1203\/01.PDR.0000113767.60140.E9","article-title":"Development and testing of new screening method for Keratan Sulfate in Mucopolysaccharidosis IVA","volume":"55","author":"Tomatsu","year":"2004","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.ymgme.2020.05.001_bb0200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-009-9036-3","article-title":"Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I","volume":"33","author":"Tomatsu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2020.05.001_bb0205","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ymgme.2018.08.003","article-title":"Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders","volume":"125","author":"Bigger","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"37","key":"10.1016\/j.ymgme.2020.05.001_bb0210","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1073\/pnas.1205858109","article-title":"Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation","volume":"109","author":"Capotondo","year":"2012","journal-title":"Proc. Natl. Acad. Sci"},{"issue":"2","key":"10.1016\/j.ymgme.2020.05.001_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2012.07.052","article-title":"Enzyme Replacement is Associated with Better Cognitive Outcomes after Transplant in Hurler Syndrome","volume":"162","author":"Eisengart","year":"2013","journal-title":"J. Pediatr."},{"issue":"12","key":"10.1016\/j.ymgme.2020.05.001_bb0220","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/nn2015","article-title":"Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions","volume":"10","author":"Mildner","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","article-title":"Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity","volume":"37","author":"Archer","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2020.05.001_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117271","article-title":"Effects of Enzyme Replacement Therapy Started Late in a Murine Model of Mucopolysaccharidosis Type I","volume":"10","author":"Pasqualim","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ymgme.2020.05.001_bb0235","first-page":"37","article-title":"Functional capacity evaluation of patients with mucopolysaccharidosis","volume":"5","author":"Guarany","year":"2012","journal-title":"J. Pediatr. Rehabil. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2020.05.001_bb0240","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2020.05.001_bb0245","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13023-015-0344-4","article-title":"Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships","volume":"10","author":"Al-Sannaa","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2020.05.001_bb0250","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/scitranslmed.3001380","article-title":"Replacing the Enzyme -L-Iduronidase at Birth Ameliorates Symptoms in the Brain and Periphery of Dogs with Mucopolysaccharidosis Type I","volume":"2","author":"Dierenfeld","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2020.05.001_bb0255","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/mt.2010.32","article-title":"Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio a syndrome","volume":"18","author":"Tomatsu","year":"2010","journal-title":"Mol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2020.05.001_bb0260","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2012.07.002","article-title":"Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model","volume":"107","author":"Rowan","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"3\u20132","key":"10.1016\/j.ymgme.2020.05.001_bb0265","article-title":"Detection of inborn errors of metabolism in the newborn","volume":"84","author":"Chakrapani","year":"2001","journal-title":"Arch. Dis. Child. - Fetal Neonatal Ed."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:25:43Z","timestamp":1761089143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220301153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1096719220301153"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.05.001","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}